Interventional reperfusion for pulmonary embolism

The management of patients with intermediate-risk pulmonary embolism (PE) has evolved in recognition of this unique population’s potential for circulatory collapse. Systemic thrombolysis, catheter-directed thrombolysis (CDT), and mechanical thrombectomy are reperfusion therapies typically reserved for patients with high-risk PE. Intermediate-risk PE represents a dynamic pathophysiologic state, whereby right ventricular dysfunction (RVD) may progress to cardiogenic shock in minutes to hours. More recent evidence suggests that early reperfusion for patients with intermediate-risk PE can have a profound impact on mortality (and adverse bleeding events) compared with anticoagulation alone. Anticoagulation is paramount in PE management, although recent trends highlight a reliance on unfractionated heparin despite evidence favoring alternative anticoagulation strategies. Modern perspectives on PE management emphasize early identification of RVD and escalation to interventional reperfusion, using vasoactive medications as a bridge to therapy.

Authors

Publication Details

Journal
JAAPA
Published
2026-11-19
DOI
https://doi.org/10.1097/01.jaa.0000000000000402
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Interventional reperfusion for pulmonary embolism

Jane Ramos
JAAPA
Venous Thromboembolism Diagnosis and Management
article

Interventional reperfusion for pulmonary embolism

Jane Ramos
article en

Abstract

The management of patients with intermediate-risk pulmonary embolism (PE) has evolved in recognition of this unique population’s potential for circulatory collapse. Systemic thrombolysis, catheter-directed thrombolysis (CDT), and mechanical thrombectomy are reperfusion therapies typically reserved for patients with high-risk PE. Intermediate-risk PE represents a dynamic pathophysiologic state, whereby right ventricular dysfunction (RVD) may progress to cardiogenic shock in minutes to hours. More recent evidence suggests that early reperfusion for patients with intermediate-risk PE can have a profound impact on mortality (and adverse bleeding events) compared with anticoagulation alone. Anticoagulation is paramount in PE management, although recent trends highlight a reliance on unfractionated heparin despite evidence favoring alternative anticoagulation strategies. Modern perspectives on PE management emphasize early identification of RVD and escalation to interventional reperfusion, using vasoactive medications as a bridge to therapy.

JAAPAVol. 39(12)
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon